SCHEMBL403025

SCHEMBL403025

COCOc1c(Br)cc(C(=O)OC)cc1C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NOTUM Q6P988 2/20 0.40
TPMT P51580 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
GAA P10253 3/20 0.39
POLB P06746 2/20 0.39
NFKB1 P19838 1/20 0.39
XDH P47989 1/20 0.39
GFER P55789 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
FUT7 Q11130 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL397989 0.90 MAPT (0.43) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL30940291 0.85 XDH (0.41) ALDH1A1KDM4EGAAPOLBXDH
SCHEMBL10205503 0.84 SMN1; SMN2 (0.53) ALDH1A1KDM4ELMNAL3MBTL1GAA
SCHEMBL403251 0.84 NOTUM (0.42) ALDH1A1KDM4ENOTUMTPMTCA12
SCHEMBL22750310 0.82 NOTUM (0.38) ALDH1A1KDM4ENOTUMTPMTCA12
SCHEMBL22750352 0.81 SMN1; SMN2 (0.45) ALDH1A1KDM4ENOTUMTPMTLMNA
SCHEMBL402248 0.80 NOTUM (0.56) KDM4ENOTUMTPMTCA12CA1
SCHEMBL403026 0.79 HSD17B10 (0.42) ALDH1A1TPMTCA12CA1CA2
SCHEMBL17201056 0.78 LMNA (0.39) ALDH1A1KDM4ETPMTLMNAL3MBTL1
SCHEMBL5989845 0.77 CA12 (0.49) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
CN-101056628-B Ester derivatives and medicinal use thereof JAPAN TOBACCO INC 2011-05-25 CN disclosed
CN-101056628-A Ester derivatives and medicinal use thereof JAPAN TOBACCO INC (JP) 2007-10-17 CN disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA ALDH1A1 421/4885KDM4E 2908/4885NOTUM 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.